- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02724748
Managing Patient Aggression in Mental Health Services (Violin)
The Effectiveness of User-driven Intervention to Manage Patient Aggression in Mental Health Services
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a single-blind, two-arm, cluster randomised controlled trial involving 28 psychiatric hospital wards across Finland.
Units are randomised on an equal basis to receive either staff educational programme (designed together with staff members, patients and relatives on the study units) or standard care. Inpatient psychiatric hospital organisations are the unit of randomisation. The cluster design will be used to avoid contamination between individual staff members in each study ward. We will use centralized randomisation at the University of Turku (Department of Mathematics and Statistics). Randomisation will be fully concealed and computer-generated by an independent statistician, who is not involved in the study. Investigators enrolling wards cannot foresee assignment. Outcome assessors and statisticians will be kept blinded to allocation. However, due to the type of intervention, allocation will be unmasked to patients and their relatives, contact persons in each ward, and health care staff delivering patient care on the wards after randomisation; this would reflect real-world care. While the Data Monitoring Committee undertook ongoing safety surveillance, investigators running the preliminary analysis for the Data Monitoring Committee will be masked to data until investigators released the database. Further, the statisticians and the National Register holder who are responsible in Finnish routine data used in this study, will be masked to ward allocation and patient data in each group. Randomisation will be done after collecting the baseline data from each unit.
Baseline data on coercive practices used on the units will be collected by the members of the research team with a help of staff members within the eight weeks, while observational and interview data related to the quality of the services will be collected by the research team (only in the intervention units). On the individual level, all staff members working in the study units, patients, and their relatives are eligible to participate in the study. Staff survey and interviews with staff members, patient groups and relatives will be done on the basis of free will. The staff of the unit/research team members will approach patients and their relatives to explain the purpose of the study and its arrangements orally and in written format. The opportunity to ask questions about the study will be given to them. Those that will be assessed having a lack of capacity to give informed consent and declined to participate will not be interviewed. Staff surveys will be repeated for baseline and follow-up. On the organisational level, the outcomes related to patient service use will be assessed 12 and 24 months after baseline data collection.
Assessing quality components: The strengths, weaknesses, opportunities, and threats related to the new practices will also be discussed and categorised based on SWOT analysis (Strength, Weakness, Opportunity, Threat). Possible barriers and facilitating factors for change on the on each unit will be identified. The quality of the service facilities will be assessed by observations on the units, based on World Health Organization's (2012) QualityRight Tool Kit focusing on five central quality criteria.
We have systematically searched for, but found no directly relevant past work. We assume that if the data will be obtained from local hospital registers by sampling 7 clusters (hospitals) with 265 subjects each in intervention group and 7 clusters with 265 subjects each in control group, we will have 80% power to detect a difference between the group proportions of -0.0400. The control group proportion is 0.1100. The intervention group proportion is assumed to be 0.1100 under the null hypothesis and 0.0700 under the alternative hypothesis. The test statistic used is the two-sided Z test (unpooled) with an overall significance level at 0.05. We may assume based on the hospital registers that sample size for the total population admitted in the study wards in one year will be 3710. However, if we consider a loss of 20% patients in the local care registers, the total number of patients on the randomised wards should be about 4454 patients. Further, if we assume 50% response rate for patient survey out of possible 3710 participants, we will assume that we will obtain 928 filled questionnaires during 6 month survey data collection period. The sample size calculation was adjusted for intra-cluster correlation at 0.005.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Finnish speaking hospital organisations
- at least 1 psychiatric ward
- open 24/7
- are able to use coersive measures (seclusion room, limb restraint, forced medication, physical restraint)
Exclusion Criteria:
- wards specialised in forensic, psychogeriatric, or child and adolescent care alone
- similar type of project is underway or is planned to start
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Educational intervention
Beside usual care the intervention will encourage collaborative practices between staff, patients and family members to adopt more human patient-centred approach on the unit.
The intervention is designed to impact on treatment culture and thereby treatment practices on the study wards.
|
Educational intervention for staff members will encourage collaboration between patients, relatives and staff members.
Skills, intellectual resources, motivation and encouragement among staff members to make changes on the unit will be supported.
More detailed content of the intervention to be used in each unit will be tailored based on preparatory phase of the study and individual needs of the unit.
The educational intervention will be carried out beside usual care.
|
No Intervention: Treatment as usual
Wards allocated to comparison wards continue with their usual care.
No restrictions on how nursing staff works in these wards, although participation in corresponding projects is not supported.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The incidence of seclusion room use.
Time Frame: Three years
|
The incidence of seclusion room use by patients in each unit.
|
Three years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Other types of coercive measures
Time Frame: Three years
|
Organisational outcomes.
Incidence of other types of coercive measures used on patients (limb restraint, forced injection, physical restraint).
|
Three years
|
Service use
Time Frame: Three years
|
Organisational outcomes.
Type of admission, length of stay, deaths.
|
Three years
|
Team climate
Time Frame: 18-20 months after beginning of the intervention
|
Staff outcomes.
Team Climate Inventory, TCI.
|
18-20 months after beginning of the intervention
|
Turnover
Time Frame: Three years
|
Staff outcomes.
|
Three years
|
The functional capacity of patients
Time Frame: Nine months after beginning of the intervention
|
Patient outcomes.
Gobal Assessment Scale, GAS.
|
Nine months after beginning of the intervention
|
Patient treatment satisfaction
Time Frame: Nine months after beginning of the intervention
|
Patient outcomes.
Client Satisfaction Questionnaire, CSQ-8.
|
Nine months after beginning of the intervention
|
Quality of Life
Time Frame: Nine months after beginning of the intervention
|
Patient outcomes.
Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form, Q-LES-Q-SF
|
Nine months after beginning of the intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Maritta Välimäki, Professor, University of Turku, Hong Kong Polytechnic University
Publications and helpful links
General Publications
- Gibbon S, Khalifa NR, Cheung NH, Vollm BA, McCarthy L. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD007668. doi: 10.1002/14651858.CD007668.pub3.
- Valimaki M, Yang M, Normand SL, Lorig KR, Anttila M, Lantta T, Pekurinen V, Adams CE. Study protocol for a cluster randomised controlled trial to assess the effectiveness of user-driven intervention to prevent aggressive events in psychiatric services. BMC Psychiatry. 2017 Apr 4;17(1):123. doi: 10.1186/s12888-017-1266-6.
- Valimaki M, Yang M, Vahlberg T, Lantta T, Pekurinen V, Anttila M, Normand SL. Trends in the use of coercive measures in Finnish psychiatric hospitals: a register analysis of the past two decades. BMC Psychiatry. 2019 Jul 26;19(1):230. doi: 10.1186/s12888-019-2200-x.
- Valimaki M, Lantta T, Anttila M, Vahlberg T, Normand SL, Yang M. An Evidence-Based Educational Intervention for Reducing Coercive Measures in Psychiatric Hospitals: A Randomized Clinical Trial. JAMA Netw Open. 2022 Aug 1;5(8):e2229076. doi: 10.1001/jamanetworkopen.2022.29076.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 294298
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aggression
-
University of KonstanzCompletedAppetitive AggressionGermany
-
New York State Psychiatric InstituteCompletedIrritable AggressionUnited States
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive AggressionUnited States
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Arizona State UniversityCompletedHeavy Drinking | Sexual AggressionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited Kingdom
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityNot yet recruitingAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityCompletedAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
Clinical Trials on Educational intervention
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBacterial Infection | Clostridium DifficileUnited States
-
McGill University Health Centre/Research Institute...University of Manitoba; Sunnybrook Health Sciences Centre; University of Alberta and other collaboratorsCompletedPeptic Ulcer Hemorrhage
-
Universidad de GranadaNot yet recruitingAsthma | Allergy
-
Roswell Park Cancer InstituteCompletedCervical Cancer | Breast CancerUnited States
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Azienda Unità Sanitaria Locale Reggio EmiliaCompletedMelanoma (Skin) | Educational ProblemsItaly
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States
-
Claudia AristizábalUniversidad Nacional de Colombia; Universidad de Santander; Fundación Universitaria...Enrolling by invitationBurnout, Psychological | CaregiversColombia